Xolair 150 MG/1.2 ML powder VLS
Ended Awarded
- Contract number
- SPE2DB25FV5EH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for XOLAIR 150 MG/1.2 ML powder vials. This firm fixed-price delivery order, valued at $1,547.40, was issued on September 3, 2025, with an ultimate completion date of September 24, 2025. The award carries no set-aside designation and represents performance at the vendor's Park Ridge, Illinois location. XOLAIR is a biologic pharmaceutical used primarily in the treatment of moderate-to-severe asthma and chronic idiopathic urticaria, and this delivery order supports the pharmaceutical supply needs of Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a significant $499.999 billion contract vehicle valid through November 2026. The SPE2DB program enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. As a trusted supplier in the federal pharmaceutical supply chain since its SAM.gov registration in 2001, DMS Pharmaceutical Group has demonstrated consistent capability in providing branded and generic prescription drugs, biologics, and medical consumables to federal agencies, making this delivery order part of the company's substantial portfolio of pharmaceutical product deliveries to the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FV5EH?
SPE2DB25FV5EH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FV5EH worth?
The government has obligated $1,547 on SPE2DB25FV5EH.
Is contract SPE2DB25FV5EH an order under another contract?
Yes. SPE2DB25FV5EH is a delivery order under SPE2DB22D9206, an indefinite delivery contract.
Was contract SPE2DB25FV5EH competed?
The extent of competition for SPE2DB25FV5EH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award